References
Pace F, Bianchi Porro G. Clinical spectrum, natural history and epidemiology of GERD. In: Granderath FA, Kamolz Th, Pointner R, editors. Gastroesophageal reflux disease, principles of disease, diagnosis and treatment. Wien New York: Springer; 2006. pp. 1–4
Toghanian S, Wahlqvist P, Johnson DA, et al. The burden of disrupting gastro-oesophageal reflux disease: a database study in US and European cohort. Clin Drug Invest 2010;30:176–8
Lenglinger J, Eisler M, Wrba F, et al. Update: histopathology-based definition of gastroesophageal reflux disease and Barrett's esophagus. Eur Surg 2008;40:165–75
Gisbert JP, Cooper A, Karagiannis D, et al. Management of gastro-oesophageal reflux disease in primary care: a European observational study. Curr Med Res Opin 2009;25:2777–84
Savarino E, Zentilin P, Tutuian R, et al. The role of nonacid reflux in NERD: lessons learned from impedance-pH monitoring in 150 patients off therapy. Am J Gastroenterol 2008;103:2685–93
Bonavina L, Saino GI, Bona D, et al. Magnetic augmentation of the lower esophageal sphincter: results of a feasibility clinical trial. J Gastroinest Surg 2008;12:2133–40
Schoppmann SF, Prager G, Langer FB, et al. Open versus minimally invasive esophagectomy: a single center case controlled study. Surg Endosc 2010;24:3044–53
Arora G, Basra S, Roorda AK, Triadafilopoulos G. Radiofrequency ablation of Barrett's esophagus. Eur Surg 2009;41:19–25
Spechler SJ, Fitzgerald RC, Prasad GA, et al. History, molecular mechanisms, and endoscopic treatment of Barrett's esophagus. Gastroenterology 2010;138:854–69
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Riegler, F. Selected Commentary to "Laparoscopic sphincter augmentation device eliminates reflux symptoms and normalizes esophageal acid exposure. One- and 2-year results of a feasibility trial". Eur Surg 42, 314–317 (2010). https://doi.org/10.1007/s10353-010-0582-6
Issue Date:
DOI: https://doi.org/10.1007/s10353-010-0582-6